信息搜索
信息关键字：药
  

共有4715条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236]

·快讯：抗癌概念股翻红 以岭药业领涨2013-7-19 13:56:06
·三普药业股东拟继续增持5%至10%公司股份2013-7-19 13:27:10
·超六成医药公司中报预喜 建议超配医药板块2013-7-19 13:10:12
·互联网金融概念“热销”泰达、天药股份涨停2013-7-19 11:05:13
·昆明制药豪赌血塞通原料药 成本压力恐成竞争短板2013-7-19 10:44:21
·68家上市药企一年会议费30亿2013-7-19 9:07:52
·中珠控股回应与美药企TNI合作事宜2013-7-19 6:46:15
·中珠控股回应与美药企TNI合作事宜2013-7-19 5:22:48
·互联网金融概念“热销”泰达天药股份涨停2013-7-19 1:28:38
·比利时制药商UCB遭中国工商部门调查2013-7-19 0:26:30
·天药股份600480_主力持仓成本 - 主力持仓成本2013-7-18 16:51:03
·*ST吉药停牌超一年后将恢复上市2013-7-18 13:34:22
·华北制药拟向大股东定增11亿元“补血”2013-7-18 12:44:17
·精华制药战略转型引狼入室 增发引入民营资本 2013-7-18 12:40:03
·医药行业上半年业绩可期 超六成公司报喜2013-7-18 11:53:43
·儿童用药市场潜在容量大 康芝药业业绩稳步增长2013-7-18 10:38:38
·康芝药业遭证监部门立案调查2013-7-18 10:38:36
·千金药业：老产品稳增 新产品还在培育期2013-7-18 9:15:01
·68只医药股支出30亿会议费 被指以开会为名行贿2013-7-18 7:44:48
·葛兰素史克罚金或不及收入1%跨国药企商业贿赂难禁2013-7-18 6:29:10

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236]